On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological
On Target Laboratories has raised $30.0M in total funding. The most recent round was Series C. The last funding was announced in November 2023.
On Target Laboratories's investors include H.I.G. Capital, Elevate Ventures, Olympus Corporation of the Americas, Johnson & Johnson Innovation, 3B Future Health Fund.
On Target Laboratories is headquartered in Northbrook, United States.
On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological
On Target Laboratories is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"On Target Laboratories — Funding & Investors." VCBacked, November 16, 2023, https://www.vcbacked.co/company/on-target-laboratories. Accessed September 14, 2026.
VCBacked. (2023). On Target Laboratories — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/on-target-laboratories
{{cite web |title=On Target Laboratories — Funding & Investors |url=https://www.vcbacked.co/company/on-target-laboratories |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated